Skip Navigation
Polsinelli's logo
  • Search
  • Our People
  • Our Capabilities
  • About Us
  • Alumni Network
  • Careers
  • Insights
    • News
    • Publications
    • Events
    • Blogs & Podcasts
  • Offices & Locations
  • Our Diverse Culture
  • Client Login
  • Contact Us

Trusts & Estates

  • Overview
  • Matters
  • People
  • News
  • Publications
  • Events

News

November 05, 2026 Awards & Recognitions
Polsinelli Earns 23 National Tier 1 Rankings in 2027 Best Law Firms List
January 12, 2026 News
Polsinelli Grows Miami Office with Trusts and Estates Shareholder Albert A. del Castillo, Jr.
Overview
Matters
People
News
Publications
Events
Firm Highlights
Slide 1 of 6
  • Publication
    3rd Quarter 2026 Chapter 11, Healthcare and Real Estate Distress Indices
    The numbers are in from the Polsinelli/TrBK Distress Index. For the Third Quarter of 2026, the U.S. Economy Distress Index decreased by over 10 points to 83.26, and the Real Estate Distress Index increased by nearly 2 points to 58.15.
    Read more
  • News
    Polsinelli Represents Blacklist Alliance in Sale to Sonera
    Polsinelli recently represented Blacklist Alliance, a provider of litigation-risk intelligence and outbound communications compliance technology, in its sale to Sonera, a compliance and deliverability platform serving businesses with regulated and outbound-intensive communications operations.
    Read more
  • News
    Polsinelli Represents Tabnam, Inc. in $50 Million Series B Financing
    Polsinelli congratulates its client Tabnam, Inc., d/b/a Greptile, on its $50 million Series B financing.
    Read more
  • Blog
    Off the Clock, On the Hook? Lidl Faces Wage Claims Over Employee Waiting Time
    Read more
  • Event
    2026 Business Law Institute Virtual Series | Part 4
    When ICE Knocks: What Employers Should Know About Navigating ICE Audits and Raids
    Read more
  • Publication
    How Earnout Trends Are Reshaping Life Sciences M&A: Key Considerations for Dealmakers
    Earnouts have become a defining feature of mergers and acquisitions in life sciences, where deal value is often tied to clinical, regulatory and commercial milestones.
    Read more
Follow us on LinkedInFollow us on Instagram
© 2026 Polsinelli. Attorney Advertising.
Prior results do not guarantee a similar outcome.
Contact UsSubscribeAlumni NetworkCollaborate PolsinelliClient Payment PortalDisclaimerCookie PreferencesPrivacy Notice